Introduction: Acinetobacter baumannii causes severe infections that primarily affect intensive
care unit (ICU) patients. It has a high prevalence of multidrug resistance, including …

Acinetobacter baumannii, most often multidrug resistant, is a difficult to treat pathogen
particularly in intensive care units. The aim of this study is to determine the prevalence and …

Background: Acinetobacter baumannii has emerged as a cause of nosocomial infections in
hospitalized patients, particularly in intensive care units. Carbapenems are a common …

Background: Nosocomial bacteremia caused by Acinetobacter baumannii (AB) is of
increasing concern in critically ill patients. There is a world-wide increase in the emergence …

Background: Acinetobacter baumannii is a common cause of multi-drug (MDR)-resistant
infections worldwide. The epidemiological and molecular characteristics of MDR-A …

Background Acinetobacter baumannii has emerged as a major cause of nosocomial
outbreaks. It is particularly associated with nosocomial pneumonia and bloodstream …

Abstract Background Multidrug resistant Acinetobacter baumannii,(MRAB) is an important
cause of hospital acquired infection. The purpose of this study is to determine the risk factors …

Objectives: To carry out a retrospective study on Acinetobacter baumannii isolates from
various clinical samples in a tertiary care hospital in India and analyze its epidemiology …

The incidence of multi-drug-resistant Acinetobacter baumannii bloodstream infections (BSIs)
increased two-to four-fold in three Israeli hospitals between 1997 and 2002, accounting for …

Introduction: Acinetobacter baumannii is an important cause of nosocomial infections
worldwide. It is difficult to control, and the infections caused by it are difficult to treat, because …